trimethyloxamine and everolimus

trimethyloxamine has been researched along with everolimus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christians, U; Serkova, NJ	1
Andreassen, AK; Arora, S; Aukrust, P; Berge, RK; Broch, K; Dellgren, G; Gude, E; Gullestad, L; Hov, JR; Karason, K; Mayerhofer, CCK; Svardal, A; Trøseid, M; Ueland, T	1

Other Studies

2 other study(ies) available for trimethyloxamine and everolimus

Article	Year
Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood. Therapeutic drug monitoring, 2005, Volume: 27, Issue:6 Topics: Animals; Biomarkers; Blood Glucose; Cholesterol; Creatine; Creatinine; Cyclosporine; Deuterium; Drug Interactions; Drug Monitoring; Everolimus; Glutathione; Hydroxybutyrates; Immunosuppressive Agents; Lactates; Magnetic Resonance Spectroscopy; Methylamines; Rats; Reproducibility of Results; Sirolimus; Time Factors	2005
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2019, Volume: 38, Issue:10 Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylamines; Microbiota; Middle Aged; Postoperative Complications	2019

Article

Year

Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood.

Therapeutic drug monitoring, 2005, Volume: 27, Issue:6

Topics: Animals; Biomarkers; Blood Glucose; Cholesterol; Creatine; Creatinine; Cyclosporine; Deuterium; Drug Interactions; Drug Monitoring; Everolimus; Glutathione; Hydroxybutyrates; Immunosuppressive Agents; Lactates; Magnetic Resonance Spectroscopy; Methylamines; Rats; Reproducibility of Results; Sirolimus; Time Factors

2005

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2019, Volume: 38, Issue:10

Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylamines; Microbiota; Middle Aged; Postoperative Complications

2019